Harmony Biosciences Holdings, Inc. HRMY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $32.49M+44.5% | $22.49M-55.8% | $50.87M+27.9% | $39.78M-12.7% | $45.56M-7.9% | ||
| $7K— | —— | $7K+16.7% | $6K-14.3% | $7K+16.7% | ||
| $10.62M+6.5% | $9.97M-9.1% | $10.97M-4.2% | $11.46M-8.4% | $12.5M+24.1% | ||
| -$3.86M— | —— | -$3.88M+40.2% | -$6.49M-50.4% | -$4.31M+35.8% | ||
| $11.44M— | —— | $7.67M— | —— | $22.94M+1,398% | ||
| -$76K+95.0% | -$1.53M— | —— | -$284K+65.1% | -$814K-388% | ||
| $10.91M— | —— | —— | $10.84M+192% | $3.72M— | ||
| $3M+112% | -$24.85M-98.3% | -$12.53M-449% | $3.59M+79.4% | $2M— | ||
| -$46.18M-188% | $52.45M+87.2% | $28.03M+499% | -$7.03M-28.8% | -$5.46M-143% | ||
| $560K+39.3% | $402K— | $0-100% | $465K-0.4% | $467K-2.9% | ||
| $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | ||
| $27.76M-78.0% | $126.15M+16.0% | $108.73M+37.1% | $79.33M+133% | $33.99M-55.0% | ||
| —— | $107K+50.7% | $71K+1,675% | $4K-96.9% | $128K-75.0% | ||
| $179M+850% | $18.84M-22.4% | $24.28M+1.6% | $23.9M+24.9% | $19.13M-46.4% | ||
| $27.35M+33.0% | $20.56M+5.1% | $19.56M+1.3% | $19.32M-10.7% | $21.62M-28.0% | ||
| -$183.65M-941% | -$17.63M-268% | -$4.79M+75.6% | -$19.59M-929% | $2.36M+133% | ||
| $5M0.0% | $5M+33.3% | $3.75M0.0% | $3.75M0.0% | $3.75M0.0% | ||
| $347K-86.9% | $2.65M+251% | $754K-64.0% | $2.1M-55.4% | $4.71M+45.4% | ||
| $2.57M+287% | $663K— | $0-100% | $1.03M-21.0% | $1.31M-41.3% | ||
| -$7.22M-139% | -$3.02M-0.6% | -$3M-11.5% | -$2.69M-663% | -$352K+87.2% | ||
| -$163.1M-255% | $105.5M+4.5% | $100.95M+76.9% | $57.05M+58.5% | $36M-45.2% | ||
| $3.32M-5.5% | $3.52M+0.3% | $3.51M+1.3% | $3.46M-17.5% | $4.2M+1.2% | ||
| $220K-21.7% | $281K-16.4% | $336K-25.8% | $453K+0.4% | $451K-8.1% | ||
| $151K-3.8% | $157K-2.5% | $161K-1.2% | $163K-1.8% | $166K-1.8% | ||
| $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | $5.96M0.0% | ||
| $7K— | —— | $7K+16.7% | $6K-14.3% | $7K+16.7% | ||
| —— | $372.5K0.0% | $372.5K0.0% | $372.5K0.0% | $372.5K+458% | ||
| $32M+653% | $4.25M-71.7% | $15M— | —— | —— | ||
| $10.91M— | —— | —— | $10.84M+192% | $3.72M— | ||
| $3M+112% | -$24.85M-98.3% | -$12.53M-449% | $3.59M+79.4% | $2M— | ||
| -$312K-198% | $320K+321% | -$145K-138% | -$61K-24.5% | -$49K— | ||
| $32M+753% | $3.75M0.0% | $3.75M0.0% | $3.75M0.0% | $3.75M-41.2% | ||
| $27.35M+33.0% | $20.56M+5.1% | $19.56M+1.3% | $19.32M-10.7% | $21.62M-28.0% | ||
| —— | $126.04M+16.0% | $108.66M+37.0% | $79.32M+134% | $33.86M-54.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.